ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate

ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate

Source: 
Biopharma Reporter
snippet: 

As the new year begins, we look at recent agreements in the global antibody drug conjugate (ADC) technology licensing space.